For laboratory research use only.
Talk of “HGH Fragment 176–191” usually means a short synthetic peptide taken from the C-terminal region of human growth hormone. The fragment is a defined research peptide, not a pocket-sized copy of the full 191-amino-acid hormone.
C-terminal GH peptides in metabolic models
Intact hGH affects lipid metabolism through multiple mechanisms. Synthetic peptides covering the extreme C-terminus were explored specifically to isolate regional contributions. A synthetic C-terminal sequence 177–191 showed antilipogenic activity in experimental systems (Ng et al., 1993), and later work examined metabolic effects of oral synthetic fragment administration in animals (Heffernan et al., 2000).
Fragment 176–191 versus AOD-9604
Catalog language often blurs fragment nicknames. Analytical doping-control work defines AOD-9604 as Tyr-hGH 177–191—an N-terminally tyrosinated 177–191 fragment—rather than as an automatic synonym for every “176–191” label (Van Eenoo et al., 2015). If a protocol cites AOD-9604 papers, an unmodified 176–191 lot is not automatically a replication material. Compare sequences before pooling data.
Why it is not “just HGH”
Full GH-receptor activation depends on a hormone architecture that can engage two receptor sites and drive dimerization. Short C-terminal peptides lack that complete architecture, which is precisely why they are interesting as regional tools and unsuitable as rhetorical substitutes for recombinant GH. Metabolic endpoints reported for fragments should stay attached to fragment papers.
Evidence boundaries
Preclinical lipid-metabolism findings are not established clinical benefit. Sports anti-doping interest in GH-related peptides is a separate regulatory discussion. For research readers, the durable contribution of this topic is chemical literacy: which sequence, which modification, which paper.
Sources
- Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone. (Biochem Mol Biol Int, 1993, PMID 8358331)
- Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism. (Am J Physiol Endocrinol Metab, 2000, PMID 10950816)
- Detection and in vitro metabolism of AOD9604. (Drug Test Anal, 2015, PMID 25208511)